Florent Heidet - 06 Mar 2025 Form 4 Insider Report for Nano Nuclear Energy Inc. (NNE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Mar 2025, 16:03:14 UTC
Next SEC filing
05 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Florent Heidet

Key filing fact

Florent Heidet filed Form 4 for Nano Nuclear Energy Inc. (NNE) on 18 Mar 2025.

Key facts

  • This page summarizes Florent Heidet's Form 4 filing for Nano Nuclear Energy Inc. (NNE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Mar 2025, 16:03.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNE transaction Derivative

Stock Options (right to purchase)

Award

Transaction value
$0
Shares
+338,000
Change %
Price
$0.000000
Shares after
0
Date
06 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
338,000
Exercise price
$26.97
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents options granted on March 6, 2025 ("Grant Date") under the Issuer's 2023 Stock Option Plan #2 to purchase an aggregate of 338,000 shares of common stock, par value $0.0001 per share, of the Issuer. The options shall vest and become exercisable once vested according to the following vesting schedule subject to Dr. Heidet's continued employment with the Issuer through each applicable vesting date and may not be exercised for a fraction of an option share. The vesting schedule includes: (i) each 57,000 shares of common stock vest and become exercisable on the first and second anniversary of the Grant Date, respectively; and (ii) each 56,000 shares of common stock vest and become exercisable on the third, fourth, fifth and sixth anniversary of the Grant Date, respectively. The options are valid for 10 years from the Grant Date until March 6, 2035.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .